RA
Rosalind Advisors’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Sell |
300,000
-312,901
| -51% | -$1.71M | 0.78% | 24 |
|
|
2025
Q1 | $3.86M | Sell |
612,901
-449,599
| -42% | -$2.83M | 1.87% | 19 |
|
|
2024
Q4 | $4.38M | Buy |
1,062,500
+312,500
| +42% | +$1.29M | 2.24% | 17 |
|
|
2024
Q3 | $2.51M | Sell |
750,000
-641,577
| -46% | -$2.14M | 1.6% | 16 |
|
|
2024
Q2 | $4.15M | Buy |
1,391,577
+465,561
| +50% | +$1.39M | 3.19% | 14 |
|
|
2024
Q1 | $3.19M | Sell |
926,016
-936,409
| -50% | -$3.23M | 2.99% | 16 |
|
|
2023
Q4 | $2.5M | Buy |
+1,862,425
| New | +$2.5M | 2.06% | 19 |
|